4.4 Article

Comparison of the antiepileptic properties of transmeningeally delivered muscimol, lidocaine, midazolam, pentobarbital and GABA, in rats

Journal

NEUROSCIENCE LETTERS
Volume 469, Issue 3, Pages 421-424

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.neulet.2009.12.042

Keywords

Muscimol; Acetylcholine; EEG seizures; Focal epilepsy; Transmeningeal pharmacotherapy

Categories

Funding

  1. Finding A Cure for Epilepsy & Seizures (FACES)
  2. Epilepsy Research Foundation [140929]

Ask authors/readers for more resources

This study compared the potencies of epidurally delivered muscimol, lidocaine, midazolam, pentobarbital and gamma-aminobutyric acid (GABA) to prevent focal neocortical seizures induced by locally applied acetylcholine (Ach), in rats (n = 5). An epidural cup was chronically implanted over the right somatosensory cortex in each animal, with epidural EEG electrodes placed posterior to the edge of the cup, After recovery, either artificial cerebrospinal fluid (ACSF: control solution) or one of the five drugs was delivered into epidural cup, followed by Ach administration into the cup to induce seizures. EEG seizure duration ratio was calculated for each drug delivery/seizure induction session to determine the potency of ACSF and the drugs to prevent the focal Ach-seizures. The concentration of all examined drug solutions was 1.0 mM. ACSF, lidocaine. midazolam, pentobarbital and GABA all failed to prevent the Ach-induced neocortical EEG seizures, yielding EEG seizure duration ratios ranging from 0.41 to 0.80. In contrast, muscimol pretreatment fully prevented the development of ictal EEG in all animals. These results suggest that when used at low concentration muscimol was the best of the five drugs for transmeningeal pharmacotherapy trials for focal neocortical epilepsy. (C) 2009 Elsevier Ireland Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Clinical Neurology

A randomized phase 2b efficacy study in patients with seizure episodes with a predictable pattern using Staccato® alprazolam for rapid seizure termination

Jacqueline French, Victor Biton, Hina Dave, Kamil Detyniecki, Michael A. Gelfand, Hui Gong, Kore Liow, Terence J. O'Brien, Ahmed Sadek, Bree DiVentura, Brittany Reich, Jouko Isojarvi

Summary: This study demonstrated that Staccato alprazolam administered via a breath-actuated device can rapidly terminate epileptic seizures in hospitalized patients. The next step is to conduct a Phase 3 confirmatory study to further evaluate the efficacy and safety of Staccato alprazolam for seizure termination in an outpatient setting.

EPILEPSIA (2023)

Article Clinical Neurology

Long- term efficacy and safety of cannabidiol in patients with treatment- resistant epilepsies: Four- year results from the expanded access program

Jerzy P. P. Szaflarski, Orrin Devinsky, Merrick Lopez, Yong D. D. Park, Pilar Pichon Zentil, Anup D. D. Patel, Elizabeth A. A. Thiele, Robert T. T. Wechsler, Daniel Checketts, Farhad Sahebkar

Summary: The CBD expanded access program initiated in 2014 provided additional CBD treatment for patients with treatment-resistant epilepsies. The study showed that CBD treatment was effective in reducing seizure frequency and had an acceptable safety profile for long-term use in patients with treatment-resistant epilepsies.

EPILEPSIA (2023)

Review Clinical Neurology

Time-to-event clinical trial designs: Existing evidence and remaining concerns

Wesley T. Kerr, Stephane Auvin, Serge Van der Geyten, Christopher Kenney, Gerald Novak, Nathan B. Fountain, Caitlin Grzeskowiak, Jacqueline A. French

Summary: Well-designed placebo-controlled clinical trials are crucial for the development of new epilepsy treatments, but the design has remained unchanged for decades. Concerns have been raised by patients, clinicians, regulators, and innovators about the challenges of recruiting for trials, partly due to the static design of maintaining participants on add-on placebo for long periods of time when there are more therapy options available. Time-to-event trials, although having potential limitations, have been suggested as a promising mechanism to make trials more patient-friendly and reduce placebo exposure.

EPILEPSIA (2023)

Article Clinical Neurology

Reasons for ineligibility for clinical trials of patients with medication-resistant epilepsy

Wesley T. Kerr, Hai Chen, Mariana Figuera Losada, Christopher Cheng, Tiffany Liu, Jaqueline French

Summary: Selection criteria for clinical trials in medication-resistant epilepsy aim to ensure safety and limit variability, but it is increasingly difficult to recruit subjects. This study investigated the impact of these criteria on recruitment at an academic epilepsy center. The majority of patients were excluded due to insufficient seizure frequency. A small proportion of patients were eligible based on common criteria, but may not be representative of the overall population.

EPILEPSIA (2023)

Article Clinical Neurology

Efficacy of cannabidiol in convulsive and nonconvulsive seizure types associated with treatment-resistant epilepsies in the Expanded Access Program

Robert J. Flamini, Anne M. Comi, E. Martina Bebin, Michael G. Chez, Gary Clark, Orrin Devinsky, Shaun A. Hussain, Paul D. Lyons, Anup D. Patel, Jillian L. Rosengard, Farhad Sahebkar, Eric Segal, Laurie Seltzer, Jerzy P. Szaflarski, Arie Weinstock

Summary: The CBD Expanded Access Program provided CBD treatment to patients with treatment-resistant epilepsy and showed a significant reduction in seizure frequency. CBD was well tolerated and effective in treating both convulsive and nonconvulsive seizure types. Controlled trials are needed to further confirm these findings.

EPILEPSIA (2023)

Editorial Material Clinical Neurology

Failure to use new breakthrough treatments for epilepsy

Pavel Klein, Gregory L. Krauss, Bernhard J. Steinhoff, Orrin Devinsky, Michael R. Sperling

Summary: Despite the approval of numerous antiseizure medications (ASMs), a significant number of epilepsy patients still experience seizures. Two new ASMs, cenobamate and fenfluramine, have shown improved efficacy in reducing seizures with sustained results. However, these medications are underutilized, likely due to limited knowledge, access restrictions, and insufficient post-launch information about their efficacy and safety. Addressing these issues can improve seizure control and ultimately reduce morbidity and mortality in epilepsy patients.

EPILEPSIA (2023)

Article Clinical Neurology

Catamenial epilepsy occurrence and patterns in a mixed population of women with epilepsy

P. Emanuela Voinescu, McKenna Kelly, Jacqueline A. French, Cynthia Harden, Anne Davis, Connie Lau, Alexa Ehlert, Stephanie Allien, Emma Osterhaus, Sarah Barnard, Rishabh Jain, Page B. Pennell

Summary: This study examined the occurrence and distribution of catamenial epilepsy patterns in women with epilepsy not receiving hormonal therapies. The results showed that out of 89 women enrolled, 23 were eligible for analysis, with 12 meeting criteria for catamenial epilepsy. App-based tracking proved to be a useful tool in determining catamenial patterns.

EPILEPSIA (2023)

Article Clinical Neurology

Fenfluramine in the treatment of Dravet syndrome: Results of a third randomized, placebo-controlled clinical trial

Joseph Sullivan, Lieven Lagae, J. Helen Cross, Orrin Devinsky, Renzo G. Guerrini, Kelly Knupp, Linda Laux, Marina Nikanorova, Tilman Polster, Dinesh Talwar, Berten Ceulemans, Rima M. Nabbout, Gail S. Farfel, Bradley R. Galer, Arnold Gammaitoni, Michael Lock, Anupam E. Agarwal, Ingrid Scheffer, FAiRE DS Study Grp

Summary: This study examined the safety and effectiveness of fenfluramine in treating convulsive seizures in patients with Dravet syndrome. The results showed that patients treated with fenfluramine had lower seizure frequency and longer interval between seizures compared to the placebo group. Common side effects of fenfluramine were observed, but no evidence of severe cardiac or vascular issues was found.

EPILEPSIA (2023)

Article Clinical Neurology

Increasing challenges to trial recruitment and conduct over time

Wesley T. T. Kerr, Advith S. S. Reddy, Sung Hyun Seo, Neo Kok, William C. C. Stacey, John M. M. Stern, Page B. B. Pennell, Jacqueline A. A. French

Summary: This study aimed to assess the changes in recruitment and retention challenges in clinical trials for focal onset epilepsy over time. A systematic analysis of randomized clinical trials was conducted to evaluate changes in participant numbers, trial sites, and countries since 1990. The study also analyzed the proportion of participants who completed each trial phase and the reasons for early trial exit. The findings highlight increasing challenges with participant recruitment and retention, as well as an increasing placebo response, emphasizing the need for changes in clinical trial design.

EPILEPSIA (2023)

Article Clinical Neurology

Later onset focal epilepsy with roots in childhood: Evidence from early learning difficulty and brain volumes in the Human Epilepsy Project

Jacob Pellinen, Heath Pardoe, Stefan Sillau, Sarah Barnard, Jacqueline French, Robert Knowlton, Daniel D. Lowenstein, Gregory Cascino, Simon Glynn, Graeme Jackson, Jerzy Szaflarski, Chris J. Morrison, Kimford Meador, Ruben Kuzniecky, Human Epilepsy Project Investigators

Summary: This study found that people with newly treated focal epilepsy and learning difficulties have lower brain tissue volume to intracranial volume, suggesting that developmental factors are an important marker of neuroanatomical changes in focal epilepsy. There were also independent associations between brain volume, age, and sex in the study population.

EPILEPSIA (2023)

Article Clinical Neurology

Patterns of antiseizure medication utilization in the Human Epilepsy Project

Jonah Fox, Sarah Barnard, Shruti H. Agashe, Manisha G. Holmes, Barry Gidal, Pavel Klein, Bassel W. Abou-Khalil, Jacqueline French, Human Epilepsy Project Investigators

Summary: More than one third of patients with focal epilepsy remain on monotherapy with their initial prescribed ASM. Approximately three out of five patients transition to monotherapy with another ASM, while approximately two out of five end up on polytherapy. Patients stay on lamotrigine for a longer duration compared to levetiracetam when it is prescribed as the initial monotherapy.

EPILEPSIA (2023)

Review Clinical Neurology

Are brief febrile seizures benign? A systematic review and narrative synthesis

Laura Gould, Victoria Delavale, Caitlin Plovnick, Thomas Wisniewski, Orrin Devinsky

Summary: Febrile seizures are associated with an increased risk of epilepsy and rare cases of sudden unexplained death. Mortality rates varied in different studies, with some reporting no deaths and others identifying a significant percentage of deaths associated with febrile seizures. Minor hippocampal histopathological anomalies were common in sudden deaths with or without a history of febrile seizures. Most electroencephalography (EEG) studies were normal, and neuroimaging studies suggested increased right hippocampal volumes. Longer-term prospective studies are needed to fully understand the outcomes of simple or brief complex febrile seizures.

EPILEPSIA (2023)

Article Pharmacology & Pharmacy

Empiric dosing strategies to predict lamotrigine concentrations during pregnancy

Jessica M. Barry, Jacqueline A. French, Page B. Pennell, Ashwin Karanam, Cynthia L. Harden, Angela K. Birnbaum

Summary: This study aims to investigate the complexity of maintaining seizure control with lamotrigine during pregnancy and evaluate the potential risks of different dosing scenarios. The results suggest that some dosing regimens may increase seizure risk or toxicity. Early clearance changes during pregnancy may require therapeutic drug monitoring to determine whether the patient belongs to the low clearance change group or the high clearance change group.

PHARMACOTHERAPY (2023)

Article Multidisciplinary Sciences

Closed-loop brain stimulation augments fear extinction in male rats

Rodrigo Ordonez Sierra, Lizeth Katherine Pedraza, Livia Barcsai, Andrea Pejin, Qun Li, Gabor Kozak, Yuichi Takeuchi, Anett J. Nagy, Magor L. Lorincz, Orrin Devinsky, Gyoergy Buzsaki, Antal Berenyi

Summary: Dysregulated fear reactions can be caused by maladaptive processing of trauma-related memories. By manipulating hippocampal SWRs and cortical oscillations, fear extinction can be enhanced in male rats. The modified fear memories become resistant to recall and do not spontaneously reemerge. This effect is mediated by D2 receptor signaling-induced synaptic remodeling in the basolateral amygdala. These findings demonstrate the potential of neuromodulation in augmenting extinction learning and provide a new avenue for anxiety disorder treatments.

NATURE COMMUNICATIONS (2023)

Article Clinical Neurology

Long-term treatment with ganaxolone for seizures associated with cyclin-dependent kinase-like 5 deficiency disorder: Two-year open-label extension follow-up

Heather E. Olson, Sam Amin, Nadia Bahi-Buisson, Orrin Devinsky, Eric D. Marsh, Elia Pestana-Knight, Rajsekar R. Rajaraman, Alex A. Aimetti, Eva Rybak, Fanhui Kong, Ian Miller, Joseph Hulihan, Scott Demarest

Summary: This study reports the 2-year safety and clinical outcomes of ganaxolone treatment in patients with CDD. The results show that ganaxolone significantly reduces major motor seizure frequency and maintains its efficacy and safety over the long term.

EPILEPSIA (2023)

Article Neurosciences

Neural correlates of social interaction anxiety and their relation to emotional intelligence: A resting-state fMRI study

Song Xue, Feng Kong, Yiying Song, Jia Liu

Summary: This study used resting-state functional magnetic resonance imaging to explore the relationship between individual's spontaneous neural activity and social interaction anxiety in a nonclinical population. The results showed that social interaction anxiety was correlated with the fractional amplitude of low-frequency fluctuations in several brain regions, and that emotional intelligence partially mediated this relationship. This study provides evidence for the neural basis of social interaction anxiety in the normal population and highlights the role of emotional intelligence in this anxiety.

NEUROSCIENCE LETTERS (2024)

Article Neurosciences

Development of the human medullary arcuate nucleus from mid-gestation to the perinatal period: A morphometric study

Katsuyuki Yamaguchi, Takuya Yazawa

Summary: This study provides morphometric data on the development of the human medullary arcuate nucleus (AN) by examining the brains of preterm and perinatal infants. The results show that AN morphology demonstrates asymmetry and individual variability during the fetal period. The volume and neuronal number of AN increase exponentially with age, while neuronal density decreases exponentially. The AN may undergo neuron death and neuroblasts production after mid-gestation.

NEUROSCIENCE LETTERS (2024)

Article Neurosciences

Transfer of massive mitochondria from astrocytes reduce propofol neurotoxicity

Zhan Zhou, Weixin Dai, Tianxiao Liu, Min Shi, Yi Wei, Lifei Chen, Yubo Xie

Summary: Studies have shown that propofol-induced neurotoxicity is caused by disruption of mitochondrial fission and fusion, leading to an energy supply imbalance for developing neurons. Healthy mitochondria released by astrocytes can migrate to compromised neurons to mitigate propofol-induced neurotoxicity, but the exact mechanisms involved still need further clarification.

NEUROSCIENCE LETTERS (2024)

Article Neurosciences

Exploring the effects of different BCI-based attention training games on the brain: A functional near-infrared spectroscopy study

An Chen, Song Hao, Yongpeng Han, Yang Fang, Yibei Miao

Summary: This study explores the efficacy of two forms of BCI attention training games and finds that physical games may be more effective than video games. The research also offers valuable insights for future game design from a neuroscience perspective.

NEUROSCIENCE LETTERS (2024)

Article Neurosciences

GDP dissociation inhibitor 1 (GDI1) attenuates β-amyloid-induced neurotoxicity in Alzheimer's diseases

Lina Liu, Luran Liu, Yunting Lu, Tianyuan Zhang, Wenting Zhao

Summary: This study reveals that GDI1 serves as a potential diagnostic biomarker for AD and inhibition of GDI1 can attenuate Aβ-induced neurotoxicity. The findings offer new insights for the treatment of AD.

NEUROSCIENCE LETTERS (2024)

Article Neurosciences

Alamandine injection in the periaqueductal gray and rostral ventromedial medulla attenuates allodynia induced by sciatic nerve ligation in rats

Zahra Gholami, Ava Soltani Hekmat, Ali Abbasi, Kazem Javanmardi

Summary: This study investigated the effects of alamandine on allodynia in a rat model and found the presence of MrgD receptors in the vlPAG and RVM regions. Microinjection of alamandine resulted in a significant increase in paw withdrawal threshold and could be blocked by an MrgD receptor antagonist. Upregulation of MrgD receptor expression following allodynia induction suggests a potential compensatory mechanism in response to pain.

NEUROSCIENCE LETTERS (2024)

Article Neurosciences

7,8-Dihydroxyflavone ameliorates cognitive impairment induced by repeated neonatal sevoflurane exposures in mice through increasing tau O-GlcNAcylation

Mingliang Xu, Lei Xia, Junjie Li, Yehong Du, Zhifang Dong

Summary: This study found that DHF effectively alleviates sevoflurane-induced cognitive impairment in developing mice by restoring the balance between tau O-GlcNAcylation and phosphorylation. Therefore, DHF has the potential to be a therapeutic agent for treating cognitive impairment associated with anesthetics, such as sevoflurane.

NEUROSCIENCE LETTERS (2024)

Article Neurosciences

Effects of transcranial electrical stimulation of the right posterior parietal cortex on physical control responses

Tsubasa Mitsutake, Hisato Nakazono, Takanori Taniguchi, Hisayoshi Yoshizuka, Maiko Sakamoto

Summary: The posterior parietal cortex plays a crucial role in postural stability, and transcranial electrical stimulation of this region can modulate physical control responses. This study found that cathodal stimulation significantly decreased joint angular velocity in multiple directions, while there were no significant differences with transcranial random noise stimulation.

NEUROSCIENCE LETTERS (2024)

Article Neurosciences

Promising efficacy of Low-Dose rituximab in Muscle specific kinase antibody positive Myasthenia Gravis

Xishuai Yang, Wei Zhang, Xueli Chang, Zuopeng Li, Runquan Du, Junhong Guo

Summary: This study aims to evaluate the efficacy of low-dose rituximab (RTX) in patients with muscle-specific kinase antibody positive myasthenia gravis (MuSK-MG). The results showed that low-dose RTX treatment led to significant improvements in clinical symptoms and quality of life for patients with MuSK-MG.

NEUROSCIENCE LETTERS (2024)

Article Neurosciences

Neuroprotective effect of plasmalogens on AlCl3-induced Alzheimer's disease zebrafish via acting on the regulatory network of ferroptosis, apoptosis and synaptic neurotransmission release with oxidative stress as the center

Jian Zhang, Shunyuan Guo, Rong Tao, Fan Wang, Yihong Xie, Huizi Wang, Lan Ding, Yuejian Shen, Xiaoli Zhou, Junli Feng, Qing Shen

Summary: This study established an Alzheimer's disease (AD) model of zebrafish induced by AlCl3 and found that marine-derived plasmalogens (Pls) could alleviate cognitive impairments of AD zebrafish by reversing athletic impairment and altering the expression levels of genes related to oxidative stress, ferroptosis, synaptic dysfunction, and apoptosis.

NEUROSCIENCE LETTERS (2024)

Article Neurosciences

A predictive model for the classification of emergency intensive care unit patients with systemic inflammatory response syndrome based on a similarity network fusion algorithm

Lu Li, Jiaqi Ren, Qi Fang, Liqiang Yu, Jintao Wang

Summary: ICU-AW is a common and severe neuromuscular complication in critically ill patients. Electrophysiological examination is essential for accurate diagnosis and early prediction of the disease. This study aimed to establish and validate an ICU-AW predictive model in SIRS patients, providing a practical tool for early clinical prediction.

NEUROSCIENCE LETTERS (2024)

Article Neurosciences

Evaluation of the separate and combined effects of anodal tDCS over the M1 and F3 regions on pain relief in patients with type-2 diabetes suffering from neuropathic pain

Ahmad Alipour, Roghayeh Mohammadi

Summary: The present study aimed to investigate the separate and combined effects of anodal transcranial direct current stimulation (tDCS) over the primary motor cortex (M1) and left dorsolateral prefrontal cortex (F3) regions on pain relief in patients with type-2 diabetes suffering from neuropathic pain (NP). The results showed that tDCS had the potential to induce pain relief in patients with type-2 diabetes suffering from NP. The mean perceived pain intensity in the posttest was lower in the M1 stimulation group than in the F3 stimulation group. However, more trials with larger sample sizes are necessary to define clinically relevant effects.

NEUROSCIENCE LETTERS (2024)

Article Neurosciences

Anxiogenic doses of rapamycin prevent URB597-induced anti-stress effects in socially defeated mice

Eduardo J. Fusse, Franciele F. Scarante, Maria A. Vicente, Mariana M. Marrubia, Flavia Turcato, Davi S. Scomparin, Melissa A. Ribeiro, Maria J. Figueiredo, Tamires A. V. Brigante, Francisco S. Guimaraes, Alline C. Campos

Summary: Repeated exposure to psychosocial stress alters the endocannabinoid system and affects brain regions associated with emotional distress. Enhancing the effects of endocannabinoids through pharmacological inhibition induces an anti-stress behavioral effect, possibly mediated by the mTOR signaling pathway.

NEUROSCIENCE LETTERS (2024)

Article Neurosciences

The cognitive architecture of verbal humor in schizophrenia

Giulia Agostoni, Luca Bischetti, Federica Repaci, Margherita Bechi, Marco Spangaro, Irene Ceccato, Elena Cavallini, Luca Fiorentino, Francesca Martini, Jacopo Sapienza, Mariachiara Buonocore, Michele Francesco D'Incalci, Federica Cocchi, Carmelo Guglielmino, Roberto Cavallaro, Marta Bosia, Valentina Bambini

Summary: This study found a general impairment in humor comprehension in individuals with schizophrenia, with mental jokes being more difficult for both patients and controls. Humor comprehension was closely associated with the patients' overall pragmatic and linguistic profile, while the association with Theory of Mind (ToM) was minimal. Another notable finding was the increased appreciation of humor in individuals with schizophrenia, who rated jokes as funnier than controls did, regardless of whether they were correctly or incorrectly completed. The funniness ratings were not predicted by any measure, suggesting a dimension of humor untied to cognition or psychopathology.

NEUROSCIENCE LETTERS (2024)

Article Neurosciences

Sevoflurane suppresses ALG13 transcription in a CREBBP-dependent manner to induce hippocampal damage and cognitive impairment

Xiuping Gong, Qi Li, Yang Liu

Summary: This study demonstrates that Sev targets CREBBP to inhibit ALG13 transcription, leading to hippocampal damage and cognitive impairment.

NEUROSCIENCE LETTERS (2024)